Mirjam Huizenga
Postdoc
- Name
- Dr. M.C.W. Huizenga
- Telephone
- +31 71 527 3539
- m.c.w.huizenga@lic.leidenuniv.nl
- ORCID iD
- 0000-0001-8313-0019
Postdoc
- Science
- Leiden Institute of Chemistry
- LIC/Chemical Biology
- Huizenga M.C.W. (10 September 2024), MAGL modulators: structure-guided optimisation and characterisation (Dissertatie. Leiden Institute of Chemistry (LIC), Faculty of Science, Leiden University). Supervisor(s) and Co-supervisor(s): Stelt M. van der, Janssen A.P.A. & Berg R.J.B.H.N. van den.
- Jiang M., Huizenga M.C.W., Mohr F., Amedi A., Bakker R., Berg R.J.B.H.N. van den, Deng H., Wel T. van der, Boeckel C.A.A. van & Stelt M. van der (2024), Structure-Activity Relationship Studies of Aryl Sulfoxides as Reversible Monoacylglycerol Lipase Inhibitors, Journal of Medicinal Chemistry 67(14): 12331-12348.
- Jiang M., Huizenga M.C.W., Wirth J.L., Paloczi J., Amedi A., Berg R.J.B.H.N. van den, Benz J., Collin L., Deng H., Di X., Driver W.F., Florea B.I., Grether U., Janssen A.P.A., Hankemeier T., Heitman L.H., Lam T.W., Mohr F., Pavlovic A., Ruf I., Hurk H. van den, Stevens A.F., Vliet D. van der, Wel T. van der, Wittwer M.B., Boeckel C.A.A. van, Pacher P., Hohmann A.G. & Stelt M. van der (2023), A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence, Nature Communications 14(1): 8039.